Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 98

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 3
Chunk 98
---
  potentially limited intellectual property protection in certain countries may limit recourse against infringing on our solutions or cause us to refrain from selling in certain geographic territ...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  staffing may be difficult along with higher turnover at international operations;  
 ─────────────────────────────────────────────────────────────────────────────────────

  transportation delays and customs related delays that may affect production and distribution of our products; and  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  integration and enforcement of laws vary significantly among jurisdictions and may change significantly over time.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

Our failure to manage any of these risks successfully
could harm our international operations and adversely impact our business, operating results and financial condition.

General Risk Factors

We incur significant increased costs as a result of operating as
a public company, and our management is required to devote substantial time to new compliance initiatives.

As a public company whose ordinary shares are listed
in the United States, we incur significant legal, accounting and other expenses that we did not incur as a private company. We are subject
to the reporting requirements of the Exchange Act, the other rules and regulations of the SEC, and the rules and regulations of Nasdaq
that apply to public companies such as us. The expenses that are required in order to be a public company are material and compliance
with the various reporting and other requirements applicable to public companies require considerable time and attention of management.
For example, the Sarbanes-Oxley Act and the rules of the SEC and national securities exchanges have imposed various requirements on public
companies, including requiring establishment and maintenance of effective disclosure and financial controls. Our management and other
personnel devote a substantial amount of time to these compliance initiatives. These rules and regulations will continue to increase our
legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect these rules
and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be
required to accept reduced policy limits on coverage or incur substantial costs to maintain the same or similar coverage. The impact of
these events could also make it more difficult for us to attract and retain qualified personnel to serve on our board of directors, our
board committees, or as executive officers.